COVID-19 Serologic Strategies for Skilled Nursing Facilities
Completed · Not applicable
Conditions studied: COVID-19
In brief
The COVID-19 pandemic ravaged United States skilled-nursing facilities (SNFs). Novel strategies that maximize the safety and quality of life for SNF residents with ADRD and staff who care for them are urgently needed. Thus, the study's objectives are: 1. To rapidly plan and pilot test an intervention that leverages COVID-19 antibody and PCR status to pair SNF staff with residents in the safest way possible 2. To reduce reduced COVID-19 incidence rate compared to SNFs not using this novel staff-resident assignment strategy.
Key facts
- Study ID
- NCT05270980
- Run by
- NYU Langone Health
- People needed
- 87
- Starts
- 2021-08-11
- Expected to finish
- 2022-02-04
- Last updated by the study team
- 2023-04-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- ArchCare at Mary Manning Walsh Home (MMW) — New York, New York, United States
- ArchCare at Terence Cardinal Cooke Health Care Center (TCC) — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.